ZYOMYX
About:
Zyomyx develops and commercializes diagnostic platforms, including a point-of-care test for HIV/AIDS.
Website: http://www.zyomyx.com
Top Investors: Bill & Melinda Gates Foundation, Jenny Rooke
Description:
Zyomyx has a unique expertise in and passion for tackling difficult “outside-the-box” problems. Highly user-friendly, instrument-free point-of-care tests need to be designed with an advanced level of cartridge engineering and reagent stability, and aligned with aggressive cost targets. Zyomyx specializes in exactly these demanding product requirements. Our immediate focus is an advanced, but simple to use and inexpensive CD4 T-cell point-of-care test that will be launched globally and configured to especially meet the demanding specifications for use in low and middle income countries.
$34.3M
$10M to $50M
Fremont, Missouri, United States
1998-01-01
info(AT)zyomyx.com
Peter Wagner
51-100
2014-03-26
Private
© 2025 bioDAO.ai